Article
CDK12: an emerging therapeutic target for cancer.
Journal of clinical pathology - 1 Nov 2018
Lui Goldie Y L, Grandori Carla, Kemp Christopher J
Abstract excerpt
Cyclin-dependent kinase 12 (CDK12) belongs to the cyclin-dependent kinase (CDK) family of serine/threonine protein kinases that regulate transcriptional and post-transcriptional processes, thereby modulating multiple cellular functions. Early studies characterised CDK12 as a transcriptional CDK that complexes with cyclin K to mediate gene transcription by phosphorylating RNA polymerase II. CDK12 has been...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
